WHO Model Lists of Essential Medicines: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (10 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
*[[Amiodarone]] | *[[Amiodarone]] | ||
*[[Amlodipine]] | *[[Amlodipine]] | ||
*[[Ampicillin]] | |||
*[[Apixaban]] | *[[Apixaban]] | ||
*[[Aprepitant]] | *[[Aprepitant]] | ||
| Line 29: | Line 30: | ||
*[[Carbamazepine]] | *[[Carbamazepine]] | ||
*[[Canagliflozin]] | *[[Canagliflozin]] | ||
*[[Cefixime]] | |||
*[[Cefotaxime]] | |||
*[[Ceftazidime]] | |||
*[[Ceftriaxone]] | |||
*[[Cefuroxime]] | |||
*[[Clarithromycin]] | *[[Clarithromycin]] | ||
*[[Clomipramine]] | *[[Clomipramine]] | ||
| Line 36: | Line 42: | ||
*[[Darunavir]] | *[[Darunavir]] | ||
*[[Dasatinib]] | *[[Dasatinib]] | ||
*[[Doxycycline]] | |||
*[[Efavirenz]] + [[Emtricitabine]] + [[Tenofovir]] | *[[Efavirenz]] + [[Emtricitabine]] + [[Tenofovir]] | ||
*[[Empagliflozin]] | *[[Empagliflozin]] | ||
| Line 50: | Line 57: | ||
*[[Imatinib]] | *[[Imatinib]] | ||
*[[Insulin glargine]] | *[[Insulin glargine]] | ||
*[[Lenalidomide]] | |||
*[[Lidocaine]] | *[[Lidocaine]] | ||
*[[Lisinopril]] + [[amlodipine]] | *[[Lisinopril]] + [[amlodipine]] | ||
| Line 68: | Line 76: | ||
*[[Ritonavir]] | *[[Ritonavir]] | ||
*[[Rituximab]] | *[[Rituximab]] | ||
*[[Rivaroxaban]] | |||
*[[Sertraline]] | *[[Sertraline]] | ||
*[[Simvastatin]] | *[[Simvastatin]] | ||
*[[Sofosbuvir]] | |||
*[[Tamoxifen]] | *[[Tamoxifen]] | ||
*[[Timolol]] | *[[Timolol]] | ||
